<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="176781">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00794066</url>
  </required_header>
  <id_info>
    <org_study_id>PARIS-Study2009</org_study_id>
    <nct_id>NCT00794066</nct_id>
  </id_info>
  <brief_title>Peripheral Arteriopathy Rate In Stroke</brief_title>
  <acronym>PARIS</acronym>
  <official_title>Prevalence of Peripheral Arterial Disease in Acute Ischemic and Hemorrhagic Stroke Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose:

      To assess the prevalence of peripheral arterial disease (PAD) in acute stroke patients.

      Interventions:

      Assessment of the ankle brachial index using the &quot;boso-ABI-system 100&quot; (www.boso.de).

      Design:

      Prospective, open, cohort study.

      Study size planned:

      1500.

      Follow-up duration:

      3 months.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2008</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Functional outcome (modified Rankin Scale)</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prevalence of peripheral arterial disease</measure>
    <time_frame>during hospital stay</time_frame>
    <description>Presence or not of PAD as assessed using ABI during hospital stay</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1500</enrollment>
  <condition>Peripheral Artery Disease</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>TIA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Ischemic stroke</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Hemorrhagic stroke</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>measuring the ankle brachial index</intervention_name>
    <description>Assessment of the ankle brachial index using the &quot;boso-ABI-system 100&quot; (www.boso.de).</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        consecutive patients with acute ischemic or hemorhagic stroke.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All consecutive adult patients with acute ischemic or hemorrhagic stroke.

        Exclusion Criteria:

          -  Congestive heart failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Schwab, MD</last_name>
    <role>Study Director</role>
    <affiliation>Head of the Department of Neurology, University of Erlangen, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Neurology, University of Erlangen, Germany</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 3, 2016</lastchanged_date>
  <firstreceived_date>November 18, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PAD</keyword>
  <keyword>Stroke</keyword>
  <keyword>ICH</keyword>
  <keyword>prevalence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
